Clinical response, drug survival and predictors thereof among 548 switchers of tumor necrosis factor alpha inhibitor therapy in psoriatic arthritis. Results from the Danish nationwide Danbio Registry.

Bente Glintborg; Mikkel Østergaard; N.S. Krogh; M.D. Andersen; U. Tarp; A.G. Loft; Hanne Merete Lindegaard; M. Holland-Fischer; H. Nordin; Dorte Vendelbo Jensen; Merete Lund Hetland

Clinical response, drug survival and predictors thereof among 548 switchers of tumor necrosis factor alpha inhibitor therapy in psoriatic arthritis. Results from the Danish nationwide Danbio Registry.

Bente Glintborg, Mikkel Østergaard, N.S. Krogh, M.D. Andersen, U. Tarp, A.G. Loft, Hanne Merete Lindegaard, M. Holland-Fischer, H. Nordin, Dorte Vendelbo Jensen, Merete Lund Hetland

Originalsprog	Engelsk
Tidsskrift	Arthritis & Rheumatism
Vol/bind	64
Udgave nummer	10 suppl.
Sider (fra-til)	S1081
Antal sider	1
ISSN	0004-3591
Status	Udgivet - 2012

Citationsformater

Glintborg, B., Østergaard, M., Krogh, N. S., Andersen, M. D., Tarp, U., Loft, A. G., Lindegaard, H. M., Holland-Fischer, M., Nordin, H., Jensen, D. V., & Hetland, M. L. (2012). Clinical response, drug survival and predictors thereof among 548 switchers of tumor necrosis factor alpha inhibitor therapy in psoriatic arthritis. Results from the Danish nationwide Danbio Registry. Arthritis & Rheumatism, 64(10 suppl.), S1081.

Clinical response, drug survival and predictors thereof among 548 switchers of tumor necrosis factor alpha inhibitor therapy in psoriatic arthritis. Results from the Danish nationwide Danbio Registry. / Glintborg, Bente; Østergaard, Mikkel; Krogh, N.S. et al.

I: Arthritis & Rheumatism, Bind 64, Nr. 10 suppl., 2012, s. S1081.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Glintborg, B, Østergaard, M, Krogh, NS, Andersen, MD, Tarp, U, Loft, AG, Lindegaard, HM, Holland-Fischer, M, Nordin, H, Jensen, DV & Hetland, ML 2012, 'Clinical response, drug survival and predictors thereof among 548 switchers of tumor necrosis factor alpha inhibitor therapy in psoriatic arthritis. Results from the Danish nationwide Danbio Registry.', Arthritis & Rheumatism, bind 64, nr. 10 suppl., s. S1081.

@article{1e2962ac40324ff9a6b3a97fa0980f53,

title = "Clinical response, drug survival and predictors thereof among 548 switchers of tumor necrosis factor alpha inhibitor therapy in psoriatic arthritis. Results from the Danish nationwide Danbio Registry.",

author = "Bente Glintborg and Mikkel {\O}stergaard and N.S. Krogh and M.D. Andersen and U. Tarp and A.G. Loft and Lindegaard, {Hanne Merete} and M. Holland-Fischer and H. Nordin and Jensen, {Dorte Vendelbo} and Hetland, {Merete Lund}",

year = "2012",

language = "English",

volume = "64",

pages = "S1081",

journal = "Arthritis & Rheumatology",

issn = "2326-5205",

publisher = "Wiley",

number = "10 suppl.",

}

TY - ABST

T1 - Clinical response, drug survival and predictors thereof among 548 switchers of tumor necrosis factor alpha inhibitor therapy in psoriatic arthritis. Results from the Danish nationwide Danbio Registry.

AU - Glintborg, Bente

AU - Østergaard, Mikkel

AU - Krogh, N.S.

AU - Andersen, M.D.

AU - Tarp, U.

AU - Loft, A.G.

AU - Lindegaard, Hanne Merete

AU - Holland-Fischer, M.

AU - Nordin, H.

AU - Jensen, Dorte Vendelbo

AU - Hetland, Merete Lund

PY - 2012

Y1 - 2012

M3 - Conference abstract in journal

SN - 2326-5205

VL - 64

SP - S1081

JO - Arthritis & Rheumatology

JF - Arthritis & Rheumatology

IS - 10 suppl.

ER -